Liraglutide – 30mg (10 vials)

Product Overview

Liraglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1). It acts on GLP-1 receptors involved in several metabolic processes, including glucose-dependent insulin secretion, appetite regulation, and gastric emptying.

Authorized liraglutide medicines are prescribed for specific indications, which vary by formulation and jurisdiction. A product bearing the name Liraglutide should not automatically be assumed to be equivalent to an authorized pharmaceutical formulation.

Scientific Background

GLP-1 receptor activation contributes to glucose regulation and influences appetite-related signaling. Liraglutide has been evaluated in clinical research and is used in certain approved medicinal products for specific metabolic conditions.

Its clinical use requires appropriate medical assessment and supervision. The evidence supporting authorized formulations does not establish the quality, safety, or effectiveness of an unverified vial product.

Product Specifications

• Product Name: Liraglutide
• Listed Strength: 30mg
• Package Size: 10 vials
• Compound Classification: GLP-1 receptor agonist
• Research Focus: GLP-1 signaling and metabolic regulation

Product Information and Verification

Before publishing this listing, verify the following details with the supplier:

• Exact ingredient identity and formulation
• Labeled strength and concentration
• Whether the product is a finished medicinal product or research material
• Package quantity and storage requirements
• Manufacturer information and applicable regulatory authorization
• Authentic quality and batch documentation

Do not claim specific purity levels, independent laboratory testing, or certificates of analysis unless supported by verifiable records.

Strength clarification: Confirm whether 30mg refers to each vial or the combined amount across all 10 vials.

Safety and Regulatory Disclaimer

Liraglutide is a prescription medicine in authorized formulations. It can cause side effects and has important contraindications and precautions. It should only be used under appropriate medical supervision when prescribed in an authorized formulation.

Do not market an unverified vial product as an approved medicine or make unsupported weight-loss, diabetes-treatment, or other therapeutic claims. Product labeling, advertising, and distribution must comply with applicable laws and regulatory requirements.

This information is provided for general educational purposes only and is not medical advice.